Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jane R. Noble is active.

Publication


Featured researches published by Jane R. Noble.


Molecular and Cellular Endocrinology | 1995

A novel human cDNA highly homologous to the fish hormone stanniocalcin

Andrew C. Chang; Jackie Janosi; Miriam Hulsbeek; Debora de Jong; Katherine J. Jeffrey; Jane R. Noble; Roger R. Reddel

Stanniocalcin is a glycoprotein hormone previously considered present only in bony fish where it is secreted by the corpuscles of Stannius, endocrine organs involved in Ca2+ homeostasis. In fish, stanniocalcin was thought to be an adaptation for Ca2+ regulation in aquatic environments, and its effects include inhibition of gill Ca2+ transport. We have obtained a human cDNA clone coding for a protein highly homologous to fish stanniocalcin. The mRNA is expressed in many human tissues, with the highest levels in ovary, prostate and thyroid. In vitro human cell culture studies show that the mRNA is positively regulated by extracellular Ca2+ in the medium. We conclude that a human protein similar to the fish hormone is expressed in multiple tissues rather than by a specialized endocrine organ.


Oncogene | 2002

Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit

Christian D. Toouli; Lily I. Huschtscha; Axel A. Neumann; Jane R. Noble; Lorel M. Colgin; Bharati Hukku; Roger R. Reddel

We directly compared two methods of immortalizing human mammary epithelial cells (HMECs). Cells were transfected with an expression plasmid either for hTERT, the catalytic subunit of telomerase, or for the simian virus 40 (SV40) early region genes. Under standard culture conditions, HMECs were not immortalized by hTERT unless they had spontaneously ceased expression of the p16INK4a tumor suppressor gene. Untransfected HMECs had low levels of telomerase expression, and immortalization by both methods was associated with an increase in telomerase activity and prevention of telomere shortening. SV40-induced immortalization was accompanied by aberrant differentiation, loss of DNA damage response, karyotypic instability and, in some cases, tumorigenicity. hTERT-immortalized cells had fewer karyotypic changes, but had intact DNA damage responses, and features of normal differentiation. Although SV40-immortalized cells are useful for studies of carcinogenesis, hTERT-immortalized cells retain more properties of normal cells.


Genes & Development | 2013

Alternative lengthening of telomeres in normal mammalian somatic cells

Axel A. Neumann; Catherine M. Watson; Jane R. Noble; Hilda A. Pickett; Patrick P.L. Tam; Roger R. Reddel

Some cancers use alternative lengthening of telomeres (ALT), a mechanism whereby new telomeric DNA is synthesized from a DNA template. To determine whether normal mammalian tissues have ALT activity, we generated a mouse strain containing a DNA tag in a single telomere. We found that the tagged telomere was copied by other telomeres in somatic tissues but not the germline. The tagged telomere was also copied by other telomeres when introgressed into CAST/EiJ mice, which have telomeres more similar in length to those of humans. We conclude that ALT activity occurs in normal mouse somatic tissues.


Oncogene | 2004

Alterations in the p16INK4a and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts

Jane R. Noble; Ze-Huai Zhong; Axel A. Neumann; John R. Melki; Susan J. Clark; Roger R. Reddel

Exogenous expression of the catalytic subunit of telomerase, hTERT, in a normal human foreskin fibroblast cell strain resulted in telomerase activity and an extended proliferative lifespan prior to a period of crisis. Three immortalized cell lines with stably maintained telomere lengths were established from cells that escaped crisis. Each of these cultures underwent a significant downregulation of p16INK4a expression due to gene deletion events. One cell line also acquired mutations in both alleles of the p53 tumor suppressor gene. Downregulation of p16INK4a and loss of wild-type p53 expression occurred after escape from crisis, so these mutations are most likely not required for immortalization of these cells but rather were selected for during continuous growth in vitro. These findings emphasize the need for caution in the use of hTERT-immortalized cells in studies of normal cell biology or in tissue engineering and the need to monitor for genetic instability and the accumulation of mutations in both the p16INK4a/pRb and p53 pathways.


Nucleic Acids Research | 2011

MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3′ untranslated region

A-Rum Yoon; Ran Gao; Zeenia Kaul; Il-Kyu Choi; Jihoon Ryu; Jane R. Noble; Yoshio Kato; Soichiro Saito; Takashi Hirano; Tetsuro Ishii; Roger R. Reddel; Chae-Ok Yun; Sunil C. Kaul; Renu Wadhwa

MicroRNAs (miRNAs) are a class of noncoding small RNAs that act as negative regulators of gene expression. To identify miRNAs that may regulate human cell immortalization and carcinogenesis, we performed comparative miRNA array profiling of human normal and SV40-T antigen immortalized cells. We found that miR-296 was upregulated in immortalized cells that also had activation of telomerase. By an independent experiment on genomic analysis of cancer cells we found that chromosome region (20q13.32), where miR-296 is located, was amplified in 28/36 cell lines, and most of these showed enriched miR-296 expression. Overexpression of miR-296 in human cancer cells, with and without telomerase activity, had no effect on their telomerase function. Instead, it suppressed p53 function that is frequently downregulated during human cell immortalization and carcinogenesis. By monitoring the activity of a luciferase reporter connected to p53 and p21WAF1 (p21) untranslated regions (UTRs), we demonstrate that miR-296 interacts with the p21-3′UTR, and the Hu binding site of p21-3′UTR was identified as a potential miR-296 target site. We demonstrate for the first time that miR-296 is frequently upregulated during immortalization of human cells and contributes to carcinogenesis by downregulation of p53-p21WAF1 pathway.


Experimental Cell Research | 1992

Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53☆

Jane R. Noble; Karen E. Willetts; W.Edward Mercer; Roger R. Reddel

Several studies have shown that expression of exogenous wild-type p53 is detrimental to the growth of cell lines with absent or mutant p53. In this study, wild-type p53 cDNA expression plasmids were transfected into A549 lung carcinoma cells which had previously been shown by sequencing to contain wild-type p53. When a constitutively expressed wild-type p53 plasmid containing the neomycin resistance gene was transfected into these cells, no G418-resistant colonies contained the exogenous p53 cDNA even though the neomycin resistance gene was integrated. When cells were transfected with a dexamethasone-inducible wild-type p53 cDNA expression plasmid, induction of p53 expression resulted in a decreased growth rate and a decreased proportion of S-phase cells. Continuous treatment with dexamethasone resulted in continued p53 expression for 16 days, but beyond that time expression ceased and could not be reinduced. These data indicated that although the A549 cell line could proliferate in the presence of endogenous wild-type p53 there was a strong selection pressure against continued expression of additional exogenous wild-type p53.


BioTechniques | 2012

Enhanced isolation of fibroblasts from human skin explants

Lily I. Huschtscha; Christine E. Napier; Jane R. Noble; Kylie Bower; Amy Y.M. Au; Hamish Campbell; Antony W. Braithwaite; Roger R. Reddel

Here we describe a method for growing fibroblasts from human skin explants that increases the number of cells obtained by up to two orders of magnitude, thus increasing the amount of material available for research and diagnostic purposes and potentially for cell-based therapies. Explants can be transferred sequentially up to 80 times, if required, at which point the explants appear to be completely depleted of fibroblasts. Utilizing skin samples obtained from 16 donors, aged 18-66 years old, the first 20 transfers produced cultures with lifespan and growth characteristics that were all very similar to each other, but the cultures derived from later transfers had a decreasing replicative capacity. Final cumulative population doublings did not correlate with donor age, but correlated positively with the telomere length at early passage. We also demonstrated that explants can be transduced directly by lentiviral infection, and that cryopreserved tissue can be explanted successfully using this procedure.


Journal of Cell Science | 2009

Normal human mammary epithelial cells proliferate rapidly in the presence of elevated levels of the tumor suppressors p53 and p21WAF1/CIP1

Lily I. Huschtscha; Jonathan D. Moore; Jane R. Noble; Hamish Campbell; Janice A. Royds; Antony W. Braithwaite; Roger R. Reddel

In normal cells, p53 protein is maintained at low levels, but the levels increase after stress or inappropriate growth signals to coordinate growth arrest or apoptosis. Human mammary epithelial cells (HMECs) are unusual in that they exhibit two phases of growth. The second growth phase, referred to as post-selection, follows a period of temporary growth arrest and is characterized by the absence of p16INK4a (also known as CDK4I and p16-INK4a) expression. Previously, we observed that post-selection HMECs have elevated levels of p53. Exogenous p16INK4a expression decreased levels of both p53 transcript and protein, and this effect was inhibited by nutlin-3a, indicating that p16INK4a can regulate p53 expression by affecting both p53 transcription and Mdm2-dependent degradation of p53. The p53 in post-selection HMECs was wild type and, as expected, increased p53 expression was associated with elevated p21WAF1/CIP1 and Mdm2 levels; the p53 response to DNA damage seemed normal. Despite elevated levels of wild-type p53 and p21WAF1/CIP1, post-selection cells grew more rapidly than their pre-selection HMEC precursors. We found that the post-selection HMECs contain a truncated Mdm2 protein (p60), which presumably lacks the p53 ubiquitylation domain. We propose that the increased levels of p53 in post-selection HMECs are due to the presence of an Mdm2 fragment that binds p53 but does not result in its degradation.


Cancer Research | 1999

Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.

Thomas R. Yeager; Axel A. Neumann; Anna Englezou; Lily I. Huschtscha; Jane R. Noble; Roger R. Reddel


Cancer Research | 1998

Loss of p16INK4 Expression by Methylation Is Associated with Lifespan Extension of Human Mammary Epithelial Cells

Lily I. Huschtscha; Jane R. Noble; Axel A. Neumann; Elsa L. Moy; Peter Barry; John R. Melki; Susan J. Clark; Roger R. Reddel

Collaboration


Dive into the Jane R. Noble's collaboration.

Top Co-Authors

Avatar

Roger R. Reddel

Children's Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Lily I. Huschtscha

Children's Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Axel A. Neumann

Children's Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Christine E. Napier

Children's Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Hamish Campbell

Children's Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar

John R. Melki

Royal Prince Alfred Hospital

View shared research outputs
Top Co-Authors

Avatar

Kylie Bower

Children's Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Susan J. Clark

Garvan Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge